Clinical

Neuroscience News logo for mobile.

Clinical trial results indicate low rate of adverse events associated with implanted brain-computer interface – Neuroscience News

Summary: A study reports that implanted brain-computer interfaces are similar in safety to more conventional brain implants used to manage neurodegenerative disorders. Source: mass general For people with paralysis caused by injury or neurological disease, such as ALS (also known as Lou Gehrig’s disease), stroke, or spinal cord injury, brain-computer interfaces (BCIs ) have the …

Clinical trial results indicate low rate of adverse events associated with implanted brain-computer interface – Neuroscience News Read More »

Dr. David Marcozzi, Clinical Director and Senior Vice President, University of Maryland Medical Center, Appointed to Additional Position of Associate Dean for UMMC Clinical Affairs at UM School of Medicine

Dr. David Marcozzi, Clinical Director and Senior Vice President, University of Maryland Medical Center, Appointed to Additional Position of Associate Dean for UMMC Clinical Affairs at UM School of Medicine

Newswise – Dean of the University of Maryland School of Medicine (UMSOM) Mark T. Gladwin, MDtoday announced that David E. Marcozzi, MD, MHS-CL, MHS-CL, FACEP, professor of emergency medicine at the University of Maryland School of Medicine (UMSOM) and clinical director/senior vice president of the University of Maryland Medical Center (UMMC), has been named associate …

Dr. David Marcozzi, Clinical Director and Senior Vice President, University of Maryland Medical Center, Appointed to Additional Position of Associate Dean for UMMC Clinical Affairs at UM School of Medicine Read More »

Bloomberg Law

Congress should seize this opportunity to correct the diversity of clinical trials

Recently, Congress missed a crucial opportunity to ensure that new drugs are tested in diverse patient populations. Ahead of its Sept. 30 expiration and despite bipartisan support for policies to improve clinical trial diversity, lawmakers passed a “clean” FDA user fee reauthorization bill stripped of public health provisions. needed to advance a more equitable clinical …

Congress should seize this opportunity to correct the diversity of clinical trials Read More »

Stony brook university hospital

Todd Griffin Named Vice President of Clinical Services and Vice Dean of Clinical Affairs at Stony Brook Medicine | | SBU News

STONY BROOK, NY, December 15, 2022 – Stony Brook Medicine named Todd Griffin, MD, MBA, as Vice President for Clinical Services and Vice Dean for Clinical Affairs. Dr. Griffin’s appointment, effective January 1, 2023, was announced by Hal Paz, MDexecutive vice president for health sciences at Stony Brook University and chief executive, Stony Brook University …

Todd Griffin Named Vice President of Clinical Services and Vice Dean of Clinical Affairs at Stony Brook Medicine | | SBU News Read More »

Carle Illinois Expands Clinical Reach to Central Illinois Region

Carle Illinois Expands Clinical Reach to Central Illinois Region

The Carle Illinois College of Medicine (CI MED) is expanding its clinical training footprint and student service to central Illinois patients with a new clinical training site in Bloomington-Normal. Beginning in March 2023, Carle BroMenn Medical Center will host rotations of CI MED students who will provide patient care in and around McLean County. CI …

Carle Illinois Expands Clinical Reach to Central Illinois Region Read More »

ASSURANCE HALLMARK CONSOLIDÉE : TRIMESTRE 3 - ÉTATS FINANCIERS 2022 |  MarketScreener

Alight Launches Targeted Behavioral Health and Cancer Offerings to Address Key Healthcare Challenges | MarketScreener

Building on Alight’s existing deep clinical capabilities, robust analytics and consumer-centric content, two new comprehensive products enable employers to take a state-specific approach to providing personalized employee support. Alight, Inc. (NYSE: ALIT), a leading provider of cloud-based human capital technologies and services, is redefining the end-to-end healthcare experience and improving outcomes with two new products …

Alight Launches Targeted Behavioral Health and Cancer Offerings to Address Key Healthcare Challenges | MarketScreener Read More »

Unique Clinical Trial Leads to Dramatic Decrease in Early Deaths from Rare and Aggressive, Yet Highly Curable Acute Promyelocytic Leukemia (APL)

Unique Clinical Trial Leads to Dramatic Decrease in Early Deaths from Rare and Aggressive, Yet Highly Curable Acute Promyelocytic Leukemia (APL)

Image: Dr. Anand Jillella see After Credit: Augusta University The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited and dedicated group of academic disease experts, has resulted in a dramatic decrease in early deaths from acute promyelocytic leukemia (APL). The discovery comes from a …

Unique Clinical Trial Leads to Dramatic Decrease in Early Deaths from Rare and Aggressive, Yet Highly Curable Acute Promyelocytic Leukemia (APL) Read More »

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine?

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine?

As 3D printing technology gains increased acceptance by pharmaceutical companies, clinical labs may see increased demand for pharmacogenomic testing Will doctors ever “print” prescription drugs for patients in the office? It sounds like science fiction, but research from University College London (UCL) indicates that the ability may be closer than we think and could lead …

University College London uses 3D printers to create personalized prescriptions, what does this mean for clinical laboratories and precision medicine? Read More »

As a Clinical Psychologist, I Believe Free Speech, Not Censorship, Benefits Mental Health: Here's Why

As a Clinical Psychologist, I Believe Free Speech, Not Censorship, Benefits Mental Health: Here’s Why

Elon Musk’s recent Twitter buying and love of free speech has sparked a storm of conversations about mental health issues related to hate speech and bullying. Calls for cancellation, removal from the platform, content throttling and other stifling measures are often made in the name of “trust and safety”. But these conversations rarely consider the …

As a Clinical Psychologist, I Believe Free Speech, Not Censorship, Benefits Mental Health: Here’s Why Read More »

ASH 2022: Longstanding new assumptions about the clinical data challenge

ASH 2022: Longstanding new assumptions about the clinical data challenge

NEW ORLEANS – In addition to news about the latest in clinical care and drug development, some startling discoveries that challenge long-held but untested assumptions are promised at the annual meeting of the American Society of Hematology. The conference begins in New Orleans on Saturday, but a sample of what’s to come was given last …

ASH 2022: Longstanding new assumptions about the clinical data challenge Read More »